Strategic Expansion The company is actively expanding manufacturing and regional hubs, including recent and planned investments in Singapore and Lisbon, creating opportunities for regional supply chain, GMP modernization, and localized validation services.

Cancer Therapeutics Focus With oncology driving a substantial portion of revenue and assets focused on ADCs, there is potential to offer targeted digital solutions, data analytics, and cloud-based manufacturing analytics tailored to oncology product lines.

Digital Infrastructure Adoption of a modern tech stack (Oracle Cloud, NetSuite, Azure AD, ELK, Drupal) positions the company for integrated ERP, CRM, and analytics partnerships; opportunities exist for advanced data integration, security, and procurement optimization.

Quality and Compliance Past mix-up incidents highlight a need for enhanced quality control, traceability, and batch/validation analytics; potential for solutions in digital quality management, inventory tracking, and incident analytics.

Global Outreach Active participation in international oncology forums and multi-region expansion signals a fit for global training, customer engagement platforms, and localization services to support regional sales and clinical collaboration.